PATENT CLAIM ANALYSIS

Application Number: 16288820
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-09
Patent Classification: ["514", "265100"]

Abstract:
The present disclosure provides methods for treating a mammal that has endometriosis using a CHRH1 antagonist composition. In some embodiments, the CHRH1 antagonist is antalarmin or an equivalent.

Claim (Index 5):
The method of  claim 1 , wherein the pharmaceutical composition further comprises one or more agents selected from the group consisting of a surfactant, a stabilizer, a biomarker, a second active pharmaceutical ingredient (API), and combinations thereof.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 99.0
- Lexical Diversity: 1.14815
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14898877', '15231239', '14377229', '14932101', '12101943']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7644868492168299
- 35 USC 102 Novelty (BERT): 0.5019191873989352
- Combined Prediction Score: 0.7382300830350403
- Mean Citation Score: 195.47161
- Max Citation Score: 205.67079
- Similarity Product: 125.65540134580851

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test